DE1933853A1 - Pyridiniumsalze enthaltende Mittel und ihre Verwendung - Google Patents

Pyridiniumsalze enthaltende Mittel und ihre Verwendung

Info

Publication number
DE1933853A1
DE1933853A1 DE19691933853 DE1933853A DE1933853A1 DE 1933853 A1 DE1933853 A1 DE 1933853A1 DE 19691933853 DE19691933853 DE 19691933853 DE 1933853 A DE1933853 A DE 1933853A DE 1933853 A1 DE1933853 A1 DE 1933853A1
Authority
DE
Germany
Prior art keywords
methyl
solution
mixture
ether
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19691933853
Other languages
German (de)
English (en)
Inventor
Wiegand Gretchen Ellen
Bauer Victor John
Fanshawe William Joseph
Safir Sidney Robert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DE1933853A1 publication Critical patent/DE1933853A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE19691933853 1968-08-07 1969-07-03 Pyridiniumsalze enthaltende Mittel und ihre Verwendung Pending DE1933853A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75075168A 1968-08-07 1968-08-07
US75572168A 1968-08-27 1968-08-27

Publications (1)

Publication Number Publication Date
DE1933853A1 true DE1933853A1 (de) 1970-02-12

Family

ID=27115318

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19691933853 Pending DE1933853A1 (de) 1968-08-07 1969-07-03 Pyridiniumsalze enthaltende Mittel und ihre Verwendung

Country Status (5)

Country Link
BE (1) BE735578A (xx)
DE (1) DE1933853A1 (xx)
FR (1) FR2015199A1 (xx)
IL (1) IL32503A0 (xx)
NL (1) NL6910401A (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2007138264A (ru) * 2005-03-17 2009-09-10 Новартис АГ (CH) N-[3-(1-АМИНО-5,6,7,8-ТЕТРАГИДРО-2,4,4b-ТРИАЗАФЛУОРЕН-9-ИЛ)ФЕНИЛ]БЕНЗАМИДЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ТИРОЗИН/ТРЕОНИНКИНАЗ, ПРЕЖДЕ ВСЕГО КИНАЗ В-RAF

Also Published As

Publication number Publication date
NL6910401A (xx) 1970-02-10
BE735578A (xx) 1970-01-05
FR2015199A1 (en) 1970-04-24
IL32503A0 (en) 1969-08-27

Similar Documents

Publication Publication Date Title
DE60309598T2 (de) Als histamin-h3-antagonisten geeignete indolderivate
DE69633332T2 (de) Alpha-substituierte pyrimidin-thioalkylderivate und alkylether als inhibitoren viraler reverser transkriptfase
DE1695093A1 (de) Neue Imidazolderivate
DD146293A5 (de) Verfahren zur herstellung von 5-(4-pyridyl)-6-(4-fluorphenyl)-2,3-dihydroimidazo eckige klammer auf 2,1-b eckige klammer zu thiazol,seiner salze und seiner oxide
HU180945B (en) Process for preparing pyrimidones
EP0736525B1 (de) Benzonitrile als 5-HT Agonisten und Antagonisten
DE3736664A1 (de) Tetrahydro-furo- und -thieno(2,3-c)pyridine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung
DE2411499A1 (de) In der 7- und 3-stellung substituierte 3,3a,4,5,6,7-hexahydro-2h-pyrazolo- eckige klammer auf 4,3-c eckige klammer zu -pyridine und deren salze, verfahren zu ihrer herstellung und arzneimittel
US4971969A (en) Pharmaceutical composition containing 1-(mono- or bis(trifluoromethyl)-2-pyridinyl)piperazines
DE2920250C2 (xx)
DD213920A5 (de) Verfahren zur herstellung von dihydropyridinen
DE3787657T2 (de) Aminosäure-Derivate.
CA1114379A (en) Piperidino-phthalazines
DE2341965A1 (de) N- eckige klammer auf 1-(omegaphenylalkyl)-piperidyl-4 eckige klammer zu -n-(alpha-pyridyl)-carbonsaeureamide, deren saeureadditionssalze, verfahren zu deren herstellung, sowie deren verwendung als arzneimittel
DE1965264A1 (de) Pyrazinoylsulfamide und Verfahren zu ihrer Herstellung
DE2638184A1 (de) Substituierte phenyl-piperazin-n- oxide, verfahren zu deren herstellung und sie enthaltende arzneimittel
CH619462A5 (en) Process for the preparation of novel piperazinylpyrazines
DE2059358A1 (de) Pyridon- und Thiopyridonderivate,die als entzuendungshemmende Mittel geeignet sind
DE2800316A1 (de) Oximether enthaltende arzneimittel zur bekaempfung von ulcera, oximether und verfahren zu ihrer herstellung
DE60103868T2 (de) N-heterocyclyl-benzen oder -pyridin-sulfonamide zur verwendung als anti-thrombogene und antikoagulierende verbindungen
DE1933853A1 (de) Pyridiniumsalze enthaltende Mittel und ihre Verwendung
DE3204403A1 (de) Neue pyridobenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2229845A1 (de) Tnazolothienodiazepinverbindung und Verfahren zu deren Herstellung
DE1695047A1 (de) Indolderivate und Verfahren zu ihrer Herstellung
EP0094080A2 (de) Pyrido(2,1-b)chinazolinderivate